To hear about similar clinical trials, please enter your email below
Trial Title:
Psychological Factors Influencing Cancer Post-traumatic Growth
NCT ID:
NCT06278558
Condition:
Cancer
Conditions: Keywords:
Cancer
Post-traumatic growth
Emotional competence
Emotional distress
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Interviews with a psychologist/psychiatrist
Description:
All patients with a high score (≥11) on the HADS anxiety and/or depressive symptoms scale
and who are not already receiving known psychological treatment or treatment mentioned in
the file will be contacted by telephone by the investigator or a qualified person
designated by him/her in order to conduct a telephone interview with the patient and
refer him/her to a psychologist or psychiatrist if necessary. The number and percentage
of consultations with a psychologist or psychiatrist following this telephone interview
will be calculated in order to highlight the benefits of such a practice (HADS assessment
+ telephone interview with +/- referral) for earlier and easier referral. Depending on
the number of patients contacted, consideration may be given to testing the effect of
this approach on post-traumatic development.
Arm group label:
Interviews with a psychologist/psychiatrist
Summary:
The study focuses on post-traumatic growth (positive changes linked to appreciation of
life, personal strengths, social relationships...) in the context of different types of
cancer and with a longitudinal approach to the care pathway. The aim of the study is to
better understand whether psychological variables (emotional competence, psychological
flexibility, psychological distress) and patients' care satisfaction, assessed at the
start of the cancer treatment pathway, can influence their post-traumatic growth at the
end of the chemotherapy protocol and 6 months later.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients over 18 years of age
- Patients in the initial phase of curative treatment for a 1st solid cancer
- At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course)
- At less than 6 months from the initial diagnosis
- Patient having given written consent to participate in the study
Exclusion Criteria:
- Patients with a previous history of cancer
- Patients with cancer progression, recurrence or relapse
- Metastatic, brain, hematological or skin cancer
- Patients who have difficulty understanding written French
- Patient psychologically or physically unable to answer questionnaires
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Centre Hospitalier de Valenciennes
Address:
City:
Valenciennes
Zip:
59300
Country:
France
Status:
Recruiting
Contact:
Last name:
FODIL Hanane
Phone:
0327140665
Email:
fodil-h@ch-valenciennes.fr
Investigator:
Last name:
Anne Sophie Baudry
Email:
Principal Investigator
Start date:
November 10, 2023
Completion date:
November 10, 2027
Lead sponsor:
Agency:
Centre Hospitalier de Valenciennes
Agency class:
Other
Collaborator:
Agency:
Ligue contre le cancer, France
Agency class:
Other
Collaborator:
Agency:
Centre Oscar Lambret
Agency class:
Other
Collaborator:
Agency:
Centre de Cancérologie Les Dentellières
Agency class:
Other
Collaborator:
Agency:
Clinique Teissier
Agency class:
Other
Source:
Centre Hospitalier de Valenciennes
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06278558
